Home › Non-Muscle Invasive Bladder Cancer

Non-Muscle Invasive Bladder Cancer clinical trials recruiting in the U.S.

33 studies for Non-Muscle Invasive Bladder Cancer are recruiting participants at sites across the United States.

Cities with the most studies

• Columbus, OH10 studies
• Dallas, TX10 studies
• New York City, NY10 studies
• Myrtle Beach, SC10 studies
• Nashville, TN9 studies
• Edison, NJ9 studies
• Syracuse, NY9 studies
• Austin, TX8 studies
• Philadelphia, PA8 studies
• Houston, TX7 studies
• Birmingham, AL7 studies
• Atlanta, GA7 studies
• Baltimore, MD7 studies
• Indianapolis, IN7 studies
• Boston, MA7 studies
• Los Angeles, CA6 studies
• Little Rock, AR6 studies
• St. Louis, MO6 studies
• San Antonio, TX6 studies
• Chicago, IL5 studies
• Bakersfield, CA5 studies
• Memphis, TN5 studies
• Cicero, IL5 studies
• Durham, NC5 studies
• Jacksonville, FL5 studies
• Washington, DC4 studies
• Kansas City, KS4 studies
• Phoenix, AZ4 studies
• Seattle, WA4 studies
• Arlington, TX4 studies
• Tampa, FL4 studies
• Cedar Rapids, IA4 studies
• Pittsburgh, PA4 studies
• Lakewood, CO4 studies
• Queens, NY4 studies
• Staten Island, NY4 studies
• East Norwalk, CT4 studies
• Greenburgh, NY4 studies
• Rochester, MN4 studies
• Troy, MI4 studies

By state

• Alabama7 studies
• Arizona11 studies
• Arkansas6 studies
• California15 studies
• Colorado5 studies
• District of Columbia4 studies
• Florida15 studies
• Georgia7 studies
• Illinois10 studies
• Indiana8 studies
• Iowa4 studies
• Kansas4 studies
• Louisiana5 studies
• Maryland8 studies
• Massachusetts11 studies
• Michigan8 studies
• Minnesota5 studies
• Missouri7 studies
• New Jersey9 studies
• New York17 studies
• North Carolina6 studies
• Ohio13 studies
• Oregon5 studies
• Pennsylvania10 studies
• South Carolina13 studies
• Tennessee11 studies
• Texas16 studies
• Virginia6 studies
• Washington5 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.